229 related articles for article (PubMed ID: 18713853)
1. Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor.
Lai JP; Lai S; Tuluc F; Tansky MF; Kilpatrick LE; Leeman SE; Douglas SD
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12605-10. PubMed ID: 18713853
[TBL] [Abstract][Full Text] [Related]
2. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
[TBL] [Abstract][Full Text] [Related]
3. Role of PKC-delta on substance P-induced chemokine synthesis in pancreatic acinar cells.
Ramnath RD; Sun J; Adhikari S; Zhi L; Bhatia M
Am J Physiol Cell Physiol; 2008 Mar; 294(3):C683-92. PubMed ID: 18160487
[TBL] [Abstract][Full Text] [Related]
4. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
5. Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.
Spitsin S; Tuluc F; Meshki J; Ping Lai J; Tustin Iii R; Douglas SD
Neuroimmunomodulation; 2013; 20(5):247-55. PubMed ID: 23921645
[TBL] [Abstract][Full Text] [Related]
6. A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization.
Li H; Leeman SE; Slack BE; Hauser G; Saltsman WS; Krause JE; Blusztajn JK; Boyd ND
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9475-80. PubMed ID: 9256507
[TBL] [Abstract][Full Text] [Related]
7. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
[TBL] [Abstract][Full Text] [Related]
8. Role of protein kinase C in caerulein induced expression of substance P and neurokinin-1-receptors in murine pancreatic acinar cells.
Koh YH; Tamizhselvi R; Moochhala S; Bian JS; Bhatia M
J Cell Mol Med; 2011 Oct; 15(10):2139-49. PubMed ID: 20973912
[TBL] [Abstract][Full Text] [Related]
9. Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis.
Douglas SD; Lai JP; Tuluc F; Schwartz L; Kilpatrick LE
Ann N Y Acad Sci; 2008 Nov; 1144():90-6. PubMed ID: 19076368
[TBL] [Abstract][Full Text] [Related]
10. Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
Monaco-Shawver L; Schwartz L; Tuluc F; Guo CJ; Lai JP; Gunnam SM; Kilpatrick LE; Banerjee PP; Douglas SD; Orange JS
J Leukoc Biol; 2011 Jan; 89(1):113-25. PubMed ID: 20940324
[TBL] [Abstract][Full Text] [Related]
11. Truncation of neurokinin-1 receptor-Negative regulation of substance P signaling.
Spitsin S; Pappa V; Douglas SD
J Leukoc Biol; 2018 Jan; ():. PubMed ID: 29345372
[TBL] [Abstract][Full Text] [Related]
12. Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells.
Koh YH; Moochhala S; Bhatia M
J Cell Mol Med; 2012 Jul; 16(7):1582-92. PubMed ID: 22040127
[TBL] [Abstract][Full Text] [Related]
13. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
14. Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions.
Lai JP; Cnaan A; Zhao H; Douglas SD
J Neurosci Methods; 2008 Feb; 168(1):127-33. PubMed ID: 18035424
[TBL] [Abstract][Full Text] [Related]
15. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
16. Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor.
Tansky MF; Pothoulakis C; Leeman SE
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10691-6. PubMed ID: 17563389
[TBL] [Abstract][Full Text] [Related]
17. Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation.
Lai JP; Ho WZ; Kilpatrick LE; Wang X; Tuluc F; Korchak HM; Douglas SD
Proc Natl Acad Sci U S A; 2006 May; 103(20):7771-6. PubMed ID: 16675550
[TBL] [Abstract][Full Text] [Related]
18. Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology.
Spitsin S; Stevens KE; Douglas SD
J Neurol Sci; 2013 Nov; 334(1-2):18-23. PubMed ID: 23916293
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals.
Jensen DD; Halls ML; Murphy JE; Canals M; Cattaruzza F; Poole DP; Lieu T; Koon HW; Pothoulakis C; Bunnett NW
J Biol Chem; 2014 Jul; 289(29):20283-94. PubMed ID: 24898255
[TBL] [Abstract][Full Text] [Related]
20. Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinase-dependent mechanism.
Meshki J; Douglas SD; Lai JP; Schwartz L; Kilpatrick LE; Tuluc F
J Biol Chem; 2009 Apr; 284(14):9280-9. PubMed ID: 19179340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
